Please try another search
Rekah Pharmaceutical Industry Ltd. (Rekah) is an Israel-based company which operates directly and through its subsidiaries. The Company operates two Good Manufacturing Practice (GMP) approved manufacturing sites, it has a marketing and distribution arm, a chain of pharmacies, and an export import unit. Rekah's plant covers approximately 5,000 square meters and was designed to take advantage of the most advanced and automated packaging techniques available. In April 1995, Rekah received the approval of the Ministry of Health for its new facility. The sterile department was designed to meet the standard of the United States Food and Drug Administration and was opened in February 1997. The Company distributes its products through Ophir & Shalpharm to institutional users such as Israel Health Funds, hospitals and government health facilities. Other subsidiaries include Vitamed Pharmaceutical Industry Ltd., CenterPharm, RITE, Talmor, BARBARA WOLF Ltd. and Madad.
Name | Age | Since | Title |
---|---|---|---|
Avraham Bigger | 75 | 2015 | Chairman |
Mordechai Elgrabli | 77 | 1993 | CEO & Director |
Georgette Elgrabli | 76 | 1993 | Director of Industrial Division & Director |
Amiram Bam | 52 | 2015 | Director |
Ishay Davidi | 61 | 2015 | Director |
Orly Zilberman | 64 | 2015 | Independent External Director |
Arnon Zo-Haaretz | 69 | 2016 | Independent External Director |
Ehud Nissan | 56 | 2016 | Independent External Director |
Are you sure you want to block %USER_NAME%?
By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.
%USER_NAME% was successfully added to your Block List
Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.
I feel that this comment is:
Thank You!
Your report has been sent to our moderators for review